{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:11:26Z","timestamp":1772032286080,"version":"3.50.1"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"56","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2019,10,8]]},"DOI":"10.18632\/oncotarget.27217","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T14:24:20Z","timestamp":1570544660000},"page":"5824-5834","source":"Crossref","is-referenced-by-count":22,"title":["Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity"],"prefix":"10.18632","volume":"10","author":[{"given":"Mark R.","family":"Woodford","sequence":"first","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Sager","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"College of Medicine, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Backe","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander J.","family":"Baker-Williams","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Bratslavsky","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, Saint Louis, MO 63110, USA"},{"name":"Hope Center for Neurological Disorders, Washington University School of Medicine, Saint Louis, MO 63110, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennady","family":"Bratslavsky","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Bourboulia","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Mollapour","sequence":"additional","affiliation":[{"name":"Department of Urology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University Syracuse, NY 13210, USA"},{"name":"Upstate Cancer Center, SUNY Upstate Medical University Syracuse, NY 13210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Jemal","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours","volume":"70","author":"Reuter","year":"2016","journal-title":"Eur Urol"},{"key":"3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00345-009-0395-z","article-title":"Economic aspects of bladder cancer: what are the benefits and costs?","volume":"27","author":"Stenzl","year":"2009","journal-title":"World J Urol"},{"key":"4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.6004\/jnccn.2018.0072","article-title":"NCCN Guidelines Insights: Bladder Cancer, Version 5.2018","volume":"16","author":"Herr","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1586\/era.11.181","article-title":"Current treatment of metastatic bladder cancer and future directions","volume":"11","author":"Pan","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"6","doi-asserted-by":"publisher","first-page":"545241","DOI":"10.5402\/2011\/545241","article-title":"Metastatic bladder cancer: a review of current management","volume":"2011","author":"Alam","year":"2011","journal-title":"ISRN Urol"},{"key":"7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12192-018-0877-2","article-title":"Methods to validate Hsp90 inhibitor specificity, to identify off-target effects, and to rethink approaches for further clinical development","volume":"23","author":"Picard","year":"2018","journal-title":"Cell Stress Chaperones"},{"key":"8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Neckers","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm.2017.20","article-title":"The HSP90 chaperone machinery","volume":"18","author":"Buchner","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.1093\/emboj\/17.16.4829","article-title":"ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone","volume":"17","author":"Pearl","year":"1998","journal-title":"EMBO J"},{"key":"11","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1083\/jcb.143.4.901","article-title":"In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis","volume":"143","author":"Hartl","year":"1998","journal-title":"J Cell Biol"},{"key":"12","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/nsmb.3305","article-title":"Importance of cycle timing for the function of the molecular chaperone Hsp90","volume":"23","author":"Buchner","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2016.03.015","article-title":"Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference","volume":"60","author":"Mamounas","year":"2016","journal-title":"Pediatr Neurol"},{"key":"14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/bs.acr.2015.09.002","article-title":"Impact of Posttranslational Modifications on the Anticancer Activity of Hsp90 Inhibitors","volume":"129","author":"Mollapour","year":"2016","journal-title":"Adv Cancer Res"},{"key":"15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.4155\/fmc.13.88","article-title":"Contributions of co-chaperones and post-translational modifications towards Hsp90 drug sensitivity","volume":"5","author":"Mollapour","year":"2013","journal-title":"Future Med Chem"},{"key":"16","doi-asserted-by":"publisher","first-page":"8454","DOI":"10.18632\/oncotarget.3502","article-title":"Targeting Hsp90 in urothelial carcinoma","volume":"6","author":"Bourboulia","year":"2015","journal-title":"Oncotarget"},{"key":"17","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.15252\/embj.201796700","article-title":"Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients","volume":"36","author":"Bourboulia","year":"2017","journal-title":"EMBO J"},{"key":"18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Manning","year":"2008","journal-title":"Biochem J"},{"key":"19","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Thiele","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.tibs.2018.09.018","article-title":"The mTOR Independent Function of Tsc1 and FNIPs","volume":"43","author":"Mollapour","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.4176","article-title":"TSC1 involvement in bladder cancer: diverse effects and therapeutic implications","volume":"230","author":"Kwiatkowski","year":"2013","journal-title":"J Pathol"},{"key":"22","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1093\/hmg\/ddn098","article-title":"Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms","volume":"17","author":"Knowles","year":"2008","journal-title":"Hum Mol Genet"},{"key":"23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/01.ju.0000074621.74361.10","article-title":"Human bladder tumors with 2-hit mutations of tumor suppressor gene TSC1 and decreased expression of p27","volume":"170","author":"Hino","year":"2003","journal-title":"J Urol"},{"key":"24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/path.1052","article-title":"Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder","volume":"196","author":"Bartlett","year":"2002","journal-title":"J Pathol"},{"key":"25","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/sj.onc.1202854","article-title":"Mutation of the 9q34 gene TSC1 in sporadic bladder cancer","volume":"18","author":"Knowles","year":"1999","journal-title":"Oncogene"},{"key":"26","first-page":"1083","article-title":"Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9","volume":"8","author":"Knowles","year":"1993","journal-title":"Oncogene"},{"key":"27","first-page":"7652","article-title":"Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder","volume":"63","author":"Cuthbert-Heavens","year":"2003","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.molcel.2013.12.007","article-title":"Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors","volume":"53","author":"Prince","year":"2014","journal-title":"Mol Cell"},{"key":"29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.18632\/oncotarget.272","article-title":"Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity","volume":"2","author":"Neckers","year":"2011","journal-title":"Oncotarget"},{"key":"30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.celrep.2015.12.084","article-title":"Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors","volume":"14","author":"Tsutsumi","year":"2016","journal-title":"Cell Reports"},{"key":"31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","article-title":"HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor","volume":"18","author":"Yao","year":"2005","journal-title":"Mol Cell"},{"key":"32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.molcel.2006.12.008","article-title":"An acetylation site in the middle domain of Hsp90 regulates chaperone function","volume":"25","author":"Neckers","year":"2007","journal-title":"Mol Cell"},{"key":"33","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.molcel.2010.01.005","article-title":"Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function","volume":"37","author":"Panaretou","year":"2010","journal-title":"Mol Cell"},{"key":"34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.molcel.2011.02.011","article-title":"Threonine 22 phosphorylation attenuates hsp90 interaction with cochaperones and affects its chaperone activity","volume":"41","author":"Pearl","year":"2011","journal-title":"Mol Cell"},{"key":"35","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.18632\/oncotarget.1099","article-title":"Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors","volume":"4","author":"Bolon","year":"2013","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T15:07:22Z","timestamp":1591456042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":35,"journal-issue":{"issue":"56","published-print":{"date-parts":[[2019,10,8]]}},"alternative-id":["27217","31645902"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27217","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,8]]}}}